Harrow Health is trading 5.36% higher at $28.70 on October 15, 2026, with the gain appearing consistent with a healthcare-sector rally.
- Available coverage cited no new company-specific announcement or catalyst explaining the move, describing the shares as lacking fresh company news.
- XLV is up 2.12%, supported by strong quarterly results and raised guidance from major healthcare companies.
- The broader market is mixed, making sector strength the more relevant context; intraday volume was not verified.